menu
    • menu

    Company profile for VectivBio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VectivBio AG is a clinical-stage biotechnology company focused on rare conditions with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with se...
    VectivBio AG is a clinical-stage biotechnology company focused on rare conditions with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and business development for innovative products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VectivBioSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Aeschenvorstadt 36 4051 Basel
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vectivbio.com/
    Linkedin
    Linkedin
    https://ch.linkedin.com/company/vectivbio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
    Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

    12 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231212626621/en

    BUSINESSWIRE
    12 Dec 2023
    Share Share
    VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
    VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

    26 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/26/2694826/0/en/VectivBio-Extraordinary-General-Meeting-of-Shareholders-Approved-All-Proposals.html

    GLOBENEWSWIRE
    26 Jun 2023
    Share Share
    Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period
    Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period

    16 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230616065227/en

    BUSINESSWIRE
    16 Jun 2023
    Share Share
    Ironwood pays $1B for VectivBio and its phase 3 GI drug
    Ironwood pays $1B for VectivBio and its phase 3 GI drug

    23 May 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eager-linzess-successor-ironwood-pays-1b-vectivbio-and-its-phase-3-gi-drug

    James Waldron FIERCE BIOTECH
    23 May 2023
    Share Share
    Ironwood Enters into Definitive Agreement to Acquire VectivBio
    Ironwood Enters into Definitive Agreement to Acquire VectivBio

    22 May 2023

    // PRESS RELEASE

    https://ir.vectivbio.com/static-files/84dc8a4e-eb10-4c88-980c-e9e8b8a99859

    PRESS RELEASE
    22 May 2023
    Share Share
    VectivBio Publishes Invitation to the Annual General Meeting
    VectivBio Publishes Invitation to the Annual General Meeting

    10 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/10/2665582/0/en/VectivBio-Publishes-Invitation-to-the-Annual-General-Meeting.html

    GLOBENEWSWIRE
    10 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search